Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Species
- (2)
- (2)
- (6)
- (6)
- (6)
- (6)
- (2)
- (13)
- (1,874)
- (103)
- (1)
- (1)
- (4)
- (51)
- (5)
- (8)
- (2)
- (15)
- (1)
- (3)
- (450)
- (8)
- (6)
- (1)
- (1)
- (28,501)
- (1)
- (8)
- (3)
- (15)
- (1)
- (3)
- (13)
- (1)
- (7)
- (1)
- (3)
- (2)
- (3)
- (4)
- (3)
- (2)
- (7)
- (3)
- (3)
- (4)
- (4)
- (2)
- (2)
- (2)
- (1)
- (4)
- (1)
- (32,564)
- (202)
- (37)
- (19)
- (17)
- (8)
- (4)
- (1)
- (3)
- (2)
- (6)
- (211)
- (2)
- (2)
- (1,328)
- (18)
- (2)
- (1)
- (2)
- (14)
- (1)
- (52)
- (2)
- (2)
- (2)
- (1)
- (42)
- (16)
- (46)
- (31)
- (2)
- (58)
- (4)
- (190)
- (1)
- (172)
- (13)
- (12)
- (3)
- (6)
- (4)
- (120)
- (4)
- (3)
- (3)
- (2)
- (2)
- (2)
- (14)
- (30,025)
- (4)
- (4,512)
- (2)
- (1)
- (4)
Regulatory Status
- (85)
- (97,403)
For Use With (Application)
- (1)
- (2)
- (1)
- (3,448)
- (1)
- (28,534)
- (30)
- (65)
- (548)
- (9,434)
- (24)
- (8)
- (2)
- (8)
- (3)
- (2)
- (2)
- (1)
- (7)
- (230)
- (2)
- (2)
- (2)
- (1)
- (2)
- (2)
- (3)
- (1)
- (5)
- (248)
- (3)
- (27,191)
- (1)
- (16)
- (1)
- (32)
- (4)
- (1)
- (49,449)
- (1,402)
- (2)
- (4)
- (3)
- (37)
- (791)
- (4)
- (3)
- (199)
- (1)
- (1)
- (134)
- (1)
- (415)
- (2,826)
- (3)
- (65)
- (7)
- (566)
- (4)
- (1)
- (19,636)
- (17)
- (2)
- (32)
- (19)
- (1)
- (3)
- (181)
- (21)
- (3)
- (121)
- (150)
- (98)
- (2)
- (2)
- (12)
- (4)
- (1)
- (1,610)
- (2)
- (4)
- (1)
- (17)
- (690)
- (2)
- (2)
- (6)
- (2)
- (21,975)
- (4,211)
- (3)
- (4)
- (1)
- (8)
- (1)
- (1)
- (1)
- (4)
- (3)
- (1)
- (1)
- (47,855)
- (197)
- (15)
- (2)
- (196)
- (62)
- (4)
- (6)
- (22)
- (1)
- (1)
- (6)
- (196)
- (1)
- (10,973)
- (4)
- (53)
- (5)
- (14)
- (2)
- (4)
- (12)
- (5)
- (8)
- (1)
- (49,831)
- (1,915)
Recombinant
- (15)
- (70,859)
Form
- (3)
- (19)
- (51,751)
- (8,477)
- (3,468)
- (136)
- (14)
- (3,408)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
1
–
15
of
83,089
results
2
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | M-CSF |
| Molecular Weight (g/mol) | 36.4 kDa |
| Gene Symbol | Csf1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MKEVSEHCSH MIGNGHLKVL QQLIDSQMET SCQIAFEFVD QEQLDDPVCY LKKAFFLVQD IIDETMRFKD NTPNANATER LQELSNNLNS CFTKDYEEQN KACVRTFHET PLQLLEKIKN FFNETKNLLE KDWNIFTKNC NNSFAKCSSR DVVTKP |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Mouse M-CSF |
| Accession Number | P07141 |
| Gene Alias | C87615; colony stimulating factor 1; colony stimulating factor 1 (macrophage); colony-stimulating factor-1 splice variant; CSF1; CSF-1; Csfm; H-MCSF; lanimostim; macrophage colony stimulating factor 1; macrophage colony stimulating factor alpha; macrophage colony stimulating factor beta; macrophage colony-stimulating factor; macrophage colony-stimulating factor 1; macrophage colony-stimulating factor beta; macrophage-colony stimulating factor alpha; MCSF; MCSF alpha; MCSFBETA; MGC31930; M-MCSF; op; osteopetrosis; Processed macrophage colony-stimulating factor 1 |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of M-NFS-60 cells is ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 12977 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
3
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >98% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | GDNF |
| Molecular Weight (g/mol) | 30.1 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 10 n/mL; determined by the dose-dependent neurite outgrowth of PC-12 cells in the presence of soluble GFR-alpha. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human GDNF |
| Purification Method | Purified |
| Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
| Protein Form | Recombinant, Ligand |
| Biological Activity | ED50 ≤ 10 n/mL; determined by the dose-dependent neurite outgrowth of PC-12 cells in the presence of soluble GFR-alpha. |
| Formulation | Protein with no preservative |
| Classification | Carrier-Free |
| Research Category | Neurobiology, Stem Cell Research, Differentiation |
| Species | Human |
| Recombinant | Recombinant |
| Shipping Condition | Approved for shipment on Wet or Dry Ice |
| Content And Storage | 4°C |
| Gene Symbol | GDNF |
| Sequence | SPDKQMAVLP RRERNRQAAA ANPENSRGKG RRGQRGKNRG CVLTAIHLNV TDLGLGYETK EELIFRYCSG SCDAAETTYD KILKNLSRNR RLVSDKVGQA CCRPIAFDDD LSFLDDNLVY HILRKHSAKR CGCI |
| Storage Requirements | 4°C |
| Protein Subtype | Neurotrophic Factors |
| Accession Number | P39905 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2668 |
| Product Line | Gibco |
4
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Thrombopoietin |
| Molecular Weight (g/mol) | 18.6 kDa |
| Gene Symbol | THPO |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SPAPPACDLR VLSKLLRDSH VLHSRLSQCP EVHPLPTPVL LPAVDFSLGE WKTQMEETKA QDILGAVTLL LEGVMAARGQ LGPTCLSSLL GQLSGQVRLL LGALQSLLGT QLPPQGRTTA HKDPNAIFLS FQHLLRGKVR FLMLVGGSTL CVRRAPPTTA VPSRTSLVLT LNEL |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Source | E. coli |
| Name | Human TPO (Thrombopoietin) |
| Accession Number | P40225 |
| Gene Alias | C-mpl ligand; Megakaryocyte colony-stimulating factor; megakaryocyte growth and development factor; megakaryocyte stimulating factor; Mgdf; MKCSF; ML; MPL ligand; Mpllg; MSA; Myeloproliferative leukemia virus oncogene ligand; prepro-thrombopoietin; TDH2A; THCYT1; THPO; Thrombopoietin; thyroid microsomal antigen; thyroid peroxidase; thyroperoxidase; Tpo; TPX |
| Biological Activity | The ED50 as determined by the dose-dependent stimulation of the proliferation of human MO7e cells was found to be ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
| Gene ID (Entrez) | 7066 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
5
Invitrogen™ Cholera Toxin Subunit B (Recombinant), Biotin-XX Conjugate
Made from a recombinant version of the B subunit only to provide a very high-purity product that is completely free of the toxic A subunit
6
Corning™ Laminin, Mouse
Promotes cell adhesion, migration, growth, and differentiation, including neurite outgrowth
7
| Protein Family | Growth Factors & Receptors |
|---|---|
| Purity or Quality Grade | >95% by SDS-PAGE |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | FGF2 |
| Molecular Weight (g/mol) | 17 kDa |
| Endotoxin Level | <0.1 ng/μg |
| Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Endotoxin Concentration | <0.1 ng/μg |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human FGF-basic (FGF-2/bFGF) (aa 10-155) |
| Purification Method | Purified |
| Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); Fibroblast growth factor basic; HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
| Protein Form | Recombinant, Ligand, Truncated |
| Biological Activity | ED50 ≤ 1.0 ng/mL; determined by the dose-dependent proliferation of BALB/3T3 cells. |
| Formulation | Protein with no preservative |
| Research Category | Neurobiology, Oncology, Stem Cell Research, Microbiology, Differentiation, Angiogenesis |
| Species | Human |
| Recombinant | Recombinant |
| Content And Storage | 4°C |
| Gene Symbol | FGF2 |
| Sequence | Human FGF-basic, amino acids 10-155 |
| Storage Requirements | 4°C |
| Protein Subtype | FGFs (Fibroblast Growth Factors) |
| Accession Number | P09038 |
| Regulatory Status | RUO |
| Product Type | Protein |
| Gene ID (Entrez) | 2247 |
| Product Line | Gibco |
8
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | PDGF-BB |
| Molecular Weight (g/mol) | 24.3 kDa |
| Gene Symbol | PDGFB |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | SLGSLTIAEP AMIAECKTRT EVFEISRRLI DRTNANFLVW PPCVEVQRCS GCCNNRNVQC RPTQVQLRPV QVRKIEIVRK KPIFKKATVT LEDHLACKCE TVAAARPVT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,Bioactivity |
| Source | E. coli |
| Name | Human PDGF-BB |
| Accession Number | P01127 |
| Gene Alias | becaplermin; c-sis; FLJ12858; H-PDGF-BB; IBGC5; PDGF; pdgf protein; PDGF subunit B; PDGF, B chain; PDGF2; PDGF-2; PDGFB; PDGF-B; platelet derived growth factor subunit B; platelet derived growth factor, B polypeptide; platelet-derived growth factor 2; platelet-derived growth factor B; platelet-derived growth factor B chain; platelet-derived growth factor beta; platelet-derived growth factor beta polypeptide; platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog); platelet-derived growth factor subunit B; platelet-derived growth factor, beta polypeptide (oncogene SIS); Platelet-derived growth factor, same as Sis (Simian sarcoma viral oncogene homologue, c-sis); proto-oncogene c-Sis; Sis; SSV |
| Biological Activity | Determined by the dose-dependent stimulation of the proliferation of Balb/c 3T3 cells.The expected ED50 for this effect is 1.0-3.0 ng/ml |
| Gene ID (Entrez) | 5155 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
9
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | IGF-I LR3 |
| Molecular Weight (g/mol) | 9.1 kDa |
| Gene Symbol | IGF1 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Source | E. coli |
| Name | Human IGF-I LR3 |
| Accession Number | P05019 |
| Gene Alias | IGF-I |
| Biological Activity | The ED50 was determined by a cell proliferation assay using FDC-P1 cells is ≤ 2.0 ng/ml, corresponding to a specific activity of ≥ 5 x 10^5 units/mg |
| Gene ID (Entrez) | 3479 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
10
Corning™ Ultrapure Laminin, Mouse
SureTRACE
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
SureTRACE
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
Supports traceability with guaranteed access to certificates and proactive change notifications.
Learn More
Promotes cell adhesion, migration, growth, and differentiation, including neurite outgrowth
12
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | Granzyme B |
| Molecular Weight (g/mol) | 26.6 kDa |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | IIGGHEAKPH SRPYMAYLMI WDQKSLKRCG GFLIRDDFVL TAAHCWGSSI NVTLGAHNIK EQEPTQQFIP VKRPIPHPAY NPKNFSNDIM LLQLERKAKR TRAVQPLRLP SNKAQVKPGQ TCSVAGWGQT APLGKHSHTL QEVKMTVQED RKCESDLRHY YDSTIELCVG DPEIKKTSFK GDSGGPLVCN KVAQGIVSYG RNNGMPPRAC TKVSSFVHWI KKTMKRYHHH HHHHH |
| Expression System | CHO cells |
| For Use With (Application) | Control,Enzyme Activity,Bioactivity |
| Name | Human Granzyme B |
| Accession Number | P10144 |
| Gene Alias | AI553453; C11; Cathepsin G-like 1; CCP1; CCP-1/C11; CCPI; CGL1; CGL-1; CSPB; CSP-B; Ctla1; Ctla-1; CTSGL1; cytotoxic cell protease 1; cytotoxic serine protease B; Cytotoxic T lymphocyte associated serine esterase 1; cytotoxic T-lymphocyte proteinase 2; cytotoxic T-lymphocyte-associated serine esterase 1; fragmentin; fragmentin 2; fragmentin-2; GLP I; GLP III; GLP-1; granzyme 2; granzyme B; granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1); granzyme B(G,H); Granzyme-2; GranzymeB; granzyme-like protein 1; granzyme-like protein I; GRB; GZB; Gzmb; HLP; human lymphocyte protein; Human lymphocyte protein (Hlp); Lymphocyte protease; Natural killer cell protease 1; OTTHUMP00000028189; RNKP-1; SECT; T-cell serine protease 1-3E |
| Format | Lyophilized |
| Biological Activity | Determined by its ability to cleave chromogentic Granzyme B substrate IEPD-pNA |
| Gene ID (Entrez) | 3002 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
13
14
MP BIOMEDICALS SARS-CoV-2 Nucleocapsid Protein His Tagged
Recombinant His-tagged SARS-CoV-2 Nucleocapsid protein, with polyhistidine tag at the N- and C-terminus. Expressed in E. coli.
| Conjugate | His-Tag |
|---|---|
| Form | Lyophilized |
| Product Type | SARS-CoV-2 Nucleocapsid Protein |
| For Use With (Application) | Drug Discovery and Development |
| Species | Human |
| Recombinant | Recombinant |
15
| Content And Storage | -20°C |
|---|---|
| Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Common Name | NTF3 |
| Molecular Weight (g/mol) | 27.2 kDa |
| Gene Symbol | Ntf3 |
| Endotoxin Concentration | <1 EU/μg |
| Sequence | MYAEHKSHRG EYSVCDSESL WVTDKSSAID IRGHQVTVLG EIKTGNSPVK QYFYETRCKE ARPVKNGCRG IDDKHWNSQC KTSQTYVRAL TSENNKLVGW RWIRIDTSCV CALSRKIGRT |
| Expression System | E. coli |
| For Use With (Application) | Control,Western Blot Control,ELISA Standard,Binding Assay,Bioactivity |
| Source | E. coli |
| Name | Human NT-3 |
| Accession Number | P20783 |
| Gene Alias | AI316846; AI835689; HDNF; Nerve growth factor 2; neurotrophic factor; neurotrophin 3; neurotrophin-3; neurotrophin-3 (HDNF/NT-3); NGF2; NGF-2; NT3; NT-3; NTF3; Ntf-3 |
| Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
| Gene ID (Entrez) | 4908 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |